ArticleScientific reports2026
Mechanistic study of TIMM44 mediating gastric carcinogenesis via the Gαi1-PI3K-AKT-mTOR signaling pathway.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Hyperglycemic conditions up - regulate TIMM44, an inner mitochondrial membrane protein. Its expression is related to many cancers, yet its role in gastric cancer (GC) remains unproven. To study this, we used western blot and qRT - PCR to measure protein and mRNA levels. Flow cytometry analyzed cell cycle progression. CCK - 8, colony formation, wound healing, Transwell, and EdU assays evaluated cell viability, migratory and invasion abilities. TUNEL - based method detected apoptosis, and immunohistochemical assay compared TIMM44 expression in GC and adjacent non - cancerous tissues. The results showed TIMM44 was highly expressed in GC tissues. Over - expressing TIMM44 promoted AGS and HGC27 cells' viability, proliferation, invasion, and migration, while its depletion inhibited these. Forced TIMM44 expression increased Gαi1 and Akt phosphorylation. In conclusion, TIMM44 is crucial in the Gαi1 - PI3K - AKT - mTOR pathway, enhancing GC cells' malignancy and potentially threatening patient survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.